Nitroglycerin: Mechanism, Forms, Dosing, and Safety for Angina
Nitroglycerin (NTG) is a short-acting venous and arterial vasodilator, first-line for acute angina pectoris due to coronary artery disease (CAD).
Mechanism
NTG → nitric oxide (NO) release → guanylate cyclase activation → ↑cGMP → smooth muscle relaxation. Preload reduction (venodilation) predominates at low doses; afterload reduction (arterial dilation) and coronary vasodilation at higher doses. Net: ↓ myocardial O₂ demand, ↑ supply.
Formulations & Onset
| Form | Onset | Duration | Typical Use |
|---|---|---|---|
| Sublingual tablet (0.3–0.6 mg) | 1–3 min | 20–30 min | Acute angina abortive |
| Sublingual spray (0.4 mg/spray) | 1–2 min | 20–30 min | Acute; easier if dry mouth |
| Transdermal patch (0.1–0.8 mg/hr) | 30–60 min | 12–24 hr | Prophylaxis (daytime only) |
| Ointment 2% (1–2 inch) | 15–30 min | 4–6 hr | Prophylaxis / variant angina |
| IV infusion | Immediate | Minutes after stop | ACS, HF, perioperative |
